ESPGHAN 2026: revisiting the key scientific highlights ESPGHAN 2026 once again brought together the neonatal community to exchange knowledge, discuss emerging evidence and explore the latest advances in neonatal nutrition. To help healthcare professionals revisit the meeting, we’ve created a dedicated resource bringing together the… Read More »ESPGHAN 2026: our scientific highlights
HealthCap invests in Neobiomics to support continued growth in neonatal care Stockholm, Sweden – 20 May 2026. Neobiomics AB, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, today announced an investment led by HealthCap, one of Europe’s… Read More »HealthCap invests in Neobiomics to support continued growth in neonatal care
Exciting News! We’re pleased to share that NeoMega36 has now been notified in Spain — an important step forward in making this innovation more widely available to clinicians and preterm infants across Europe.NeoMega36 is specifically developed to support the development of normal visual function in preterm infants, contributing to healthier… Read More »NeoMega36 now available in Spain
This January, Neobiomics, represented by Carla Martino, had the pleasure of participating in two major neonatology conferences in Italy: January 11 – Rimini: The Family in the Neonatal Intensive Care Unit: Connection to Overcome Polarization January 16-17 – Rome: 6th Meeting on Fetal-Neonatal Medicine and… Read More »Double Appointment in Italy to Kick Off 2025: Rimini and Rome!
We are excited to announce that NeoMega36® has officially made its way to Norway! This marks the sixth country where our innovative solution is now in use, and we couldn’t be happier to welcome our first Norwegian customer. Expanding into new markets is an important… Read More »NeoMega36® has reached Norway